Avalo Therapeutics Inc
AVTX
NASDAQ
Biotechnology
$19.59
USD
+0.14 (+0.72%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $1.04B
Volume 387.5K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
REPL | Replimune Group Inc | $1.28B | - | - | - | |
SANA | Sana Biotechnology Inc | $1.10B | - | - | - | |
ODTX | Odyssey Therapeutics Inc | $1.07B | - | -19.0% | - | |
AVTX | Avalo Therapeutics Inc | $1.04B | - | -86.6% | - | |
GERN | Geron Corp | $1.01B | - | +24.4% | - | |
JANX | Janux Therapeutics Inc | $978.19M | - | +5367.0% | - | |
ARDX | Ardelyx Inc | $974.32M | - | +16.8% | - | |
KURA | Kura Oncology Inc | $915.26M | - | - | - | |
DSGN | Design Therapeutics Inc | $900.55M | - | - | - | |
ANNX | Annexon Inc | $856.08M | - | - | - |
Top Peer by Growth
Janux Therapeutics Inc
+5367.0% YoY Revenue
Best 1-Year Return
Avalo Therapeutics Inc
+114.3% Return